Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2874-2881

  Wang, Sumin ^a   Wang, Furu ^a   Shi, Xiaoyan ^a   Dai, Juncheng ^a   Peng, Yuzhu ^a   Guo, Xirong ^a   Wang, Xinru ^a   Shen, Hongbing ^a   Hu, Zhibin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Cancer; MnSOD; Polymorphism; Susceptibility

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; MANGANESE SUPEROXIDE DISMUTASE;

ALLELE; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; META ANALYSIS; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CASE-CONTROL STUDIES; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 70350026896     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.024     Document Type: Article

References (69)

1. Feig D.I., Reid T.M., and Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res 54 (1994) 1890s-1894s
2. de Zwart L.L., Meerman J.H., Commandeur J.N., and Vermeulen N.P. Biomarkers of free radical damage: applications in experimental animals and in humans. Free Radic Biol Med 26 (1999) 202-226
3. Forsberg L., de Faire U., and Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389 (2001) 84-93
4. Schwartz J.L., Antoniades D.Z., and Zhao S. Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann NY Acad Sci 686 (1993) 262-278 discussion 278-9
5. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 16 (1994) 99-109
6. Cooke M.S., Evans M.D., Dizdaroglu M., and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17 (2003) 1195-1214
7. Li H., Kantoff P.W., Giovannucci E., et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65 (2005) 2498-2504
8. Macmillan-Crow L.A., and Cruthirds D.L. Invited review: manganese superoxide dismutase in disease. Free Radic Res 34 (2001) 325-336
9. Thompson P.A., and Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr (2000) 125-134
10. Ambrosone C.B., Freudenheim J.L., Thompson P.A., et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 59 (1999) 602-606
11. Wispé J.R., Clark J.C., Burhans M.S., Kropp K.E., Korfhagen T.R., and Whitsett J.A. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta 994 (1989) 30-36
12. Pfanner N., and Geissler A.V. Ersatility of the mitochondrial protein import machinery. Nat Rev Mol Cell Biol 2 (2001) 339-349
13. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., and Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226 (1996) 561-565
14. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., and Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13 (2003) 145-157
15. Mitrunen K., Sillanpää P., Kataja V., et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22 (2001) 827-829
16. Green H., Ross G., Peacock J., Owen R., Yarnold J., and Houlston R. Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients. Radiother Oncol 63 (2002) 213-216
17. Egan K.M., Thompson P.A., Titus-Ernstoff L., Moore J.H., and Ambrosone C.B. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett 199 (2003) 27-33
18. Millikan R.C., Player J., de Cotret A.R., et al. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 6 (2004) R264-R274 Epub 2004 Apr 7
19. Cai Q., Shu X.O., Wen W., et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 6 (2004) R647-R655 Epub 2004 Sep 22
20. Tamimi R.M., Hankinson S.E., Spiegelman D., Colditz G.A., and Hunter D.J. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 989-996
21. Bergman M., Ahnström M., Palmebäck Wegman P., and Wingren S. Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol 131 (2005) 439-444 Epub 2005 May 10
22. Gaudet M.M., Gammon M.D., Santella R.M., et al. MnSOD Val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 16 (2005) 1225-1234
23. Cheng T.C., Chen S.T., Huang C.S., et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility. Int J Cancer 113 (2005) 345-353
24. Silva S.N., Cabral M.N., Bezerra de Castro G., et al. Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17β1, COMT and MnSOD): Possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed. Oncol Rep 16 (2006) 781-788
25. Slanger T.E., Chang-Claude J., and Wang-Gohrke S. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population. Cancer Causes Control 17 (2006) 1025-1031
26. Bica C.G., de Moura da Silva L.L., Toscani N.V., et al. MnSOD Gene polymorphism association with steroid-dependent cancer. Pathol Oncol Res (2008) [Epub ahead of print]
27. Woodson K., Tangrea J.A., Lehman T.A., et al. Manganese superoxide dismutase (MnSOD) polymorphism, a-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland). Cancer Causes Control 14 (2003) 513-518
28. Kang D., Lee K.M., Park S.K., et al. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study. Cancer Epidemiol Biomarkers Prev 16 (2007) 1581-1586
29. Ergen H.A., Narter F., Timirci O., and Isbir T. Effects of manganese superoxide dismutase Ala-9Val polymorphism on prostate cancer: A case-control study. Anticancer Res 27 (2007) 1227-1230
30. Mikhak B., Hunter D.J., Spiegelman D., et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels, and prostate cancer risk. Carcinogenesis (2008) [Epub ahead of print]
31. Choi J.Y., Neuhouser M.L., Barnett M.J., et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 29 (2008) 964-970 Epub 2008 Feb 22
32. Iguchi T., Wang C.Y., Delongchamps N.B., et al. Association of prostate cancer and manganese superoxide dismutase AA genotype influenced by presence of occult cancer in control group. Urology 72 (2008) 238-241 discussion 241-2. Epub 2008 Jun 24
33. Arsova-Sarafinovska Z., Matevska N., Petrovski D., et al. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem Funct 26 (2008) 771-777
34. Hirvonen A., Tuimala J., Ollikainen T., Linnainmaa K., and Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett 178 (2002) 71-74
35. Lin P., Hsueh Y.M., Ko J.L., Liang Y.F., Tsai K.J., and Chen C.Y. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung cancer 40 (2003) 123-129
36. Wang L.I., Neuberg D., and Christiani D.C. Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype, and lung cancer risk. J Occup Environ Med 46 (2004) 556-564
37. Ho J.C., Mak J.C., Ho S.P., et al. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. J Thorac Oncol 1 (2006) 648-653
38. Hung R.J., Boffetta P., Brennan P., et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 25 (2004) 973-978
39. Ichimura Y., Habuchi T., Tsuchiya N., et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 172 (2004) 728-732
40. di Martino E., Hardie L.J., Wild C.P., et al. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med 9 (2007) 341-347
41. Murphy S.J., Hughes A.E., Patterson C.C., et al. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis 28 (2007) 1323-1328
42. Li D., Firozi P.F., Zhang W., et al. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer. Mutat Res 513 (2002) 37-48
43. Martin R.C., Lan Q., Hughes K., et al. No apparent association between genetic polymorphisms (-102 C>T) and (-9 T>C) in the human manganese superoxide dismutase gene and gastric cancer. J Surg Res 124 (2005) 92-97
44. Johnatty S.E., Nagle C.M., Spurdle A.B., et al. The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia). Gynecol Oncol 107 (2007) 388-391
45. Landi S., Gemignani F., Neri M., et al. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer 120 (2007) 2739-2743
46. Han J., Colditz G.A., and Hunter D.J. Manganese superoxide dismutase polymorphism and risk of skin cancer (United States). Cancer Causes Control 18 (2007) 79-89
47. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
48. Dupont W.D., and Plummer Jr. W.D. Power and sample size calculations for studies involving linear regression. Control Clin Trials 19 (1998) 589-601
49. Xu Y., Porntadavity S., and St Clair D.K.T. Ranscriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp 1) and activating protein-2 (AP-2). Biochem J 362 (2002) 401-412
50. Li Y., Huang T.T., Carlson E.J., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11 (1995) 376-381
51. Lebovitz R.M., Zhang H., Vogel H., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93 (1996) 9782-9787
52. Zhong W., Oberley L.W., Oberley T.D., and St Clair D.K. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14 (1997) 481-490
53. Oberley T.D. Mitochondria, manganese superoxide dismutase, and cancer. Antioxid Redox Signal 6 (2004) 483-487
54. Li N., Oberley T.D., Oberley L.W., and Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 35 (1998) 221-233
55. Li Z., Khaletskiy A., Wang J., Wong J.Y., Oberley L.W., and Li J.J. Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase. Free Radic Biol Med 30 (2001) 260-267
56. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., and Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 226 (1996) 561-565
57. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., and Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13 (2003) 145-157
58. Kinnula V.L., and Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 36 (2004) 718-744
59. Plymate S.R., Haugk K.H., Sprenger C.C., et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene 22 (2003) 1024-1034
60. Duan H., Zhang H.J., Yang J.Q., Oberley L.W., Futscher B.W., and Domann F.E. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells. Antioxid Redox Signal 5 (2003) 677-688
61. Venkataraman S., Jiang X., Weydert C., et al. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24 (2005) 77-89
62. Lim S.D., Sun C., Lambeth J.D., et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62 (2005) 200-207
63. Wenk J., Brenneisen P., Wlaschek M., et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274 (1999) 25869-25876
64. Lockett K.L., Hall M.C., Clark P.E., et al. DNA damage levels in prostate cancer cases and controls. Carcinogenesis 27 (2006) 1187-1193 Epub 2005 Dec 19
65. Polytarchou C., Hatziapostolou M., and Papadimitriou E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 280 (2005) 40428-40435 Epub 2005 Sep 30
66. Sharifi N., Hurt E.M., Thomas S.B., and Farrar W.L. Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: Implications for castration-resistant prostate cancer. Clin Cancer Res 14 (2008) 6073-6080
67. El-Bayoumy K., and Sinha R. Molecular chemoprevention by selenium: a genomic approach. Mutat Res 591 (2005) 224-236
68. Kłapcińska B., Jagsz S., Sadowska-Krepa E., Górski J., Kempa K., and Langfort J. Effects of castration and testosterone replacement on the antioxidant defense system in rat left ventricle. J Physiol Sci 58 (2008) 173-177
69. Chowdhury S.K., Raha S., Tarnopolsky M.A., and Singh G. Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer. Free Radic Res 41 (2007) 1116-1124